Science Explorer Back to mapMap
Discussion
Topic · Infectious Diseases

Amoebic Infections and Treatments

Amoebic Infections and Treatments is a research topic within Infectious Diseases. Science Explorer counts 22k research works in it since 1950. 10.1% of them reached the world's top 10% most cited for their field and year.

This cluster of papers focuses on the pathogenesis, clinical management, diagnosis, and treatment of amoebiasis, with a specific emphasis on Entamoeba histolytica infections and pyogenic liver abscesses. It covers topics such as laboratory diagnosis techniques, cysteine proteases involved in pathogenesis, epidemiology, percutaneous drainage, and the host immune response to the infection.

  • Entamoeba histolytica
  • pyogenic liver abscess
  • diagnosis
  • treatment
  • pathogenesis
  • laboratory diagnosis
  • cysteine proteases
  • epidemiology
  • percutaneous drainage
  • immune response
Research works
22k
fractional, since 1950
In the world top 10%
2.2k
per year above
Top-10% rate
10.1%
share of its works in the world top 10%
Growth, 2018-21 → 2022-25
+2%
the tick is no change
Largest producer
United States
24% of the 10 largest, 2022-now
Amoebic Infections and Treatments

This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.

Which countries lead Amoebic Infections and Treatments research?

By volume, the United States and China publish the most (508 and 482 works in 2022-now).

By volume, 2022-now

  1. 1 United States 508 works
  2. 2 China 482 works
  3. 3 India 341 works
  4. 4 Japan 146 works
  5. 5 Türkiye 127 works
  6. 6 Iraq 125 works
  7. 7 United Kingdom 114 works
  8. 8 Brazil 92 works
  9. 9 Germany 92 works
  10. 10 Iran 92 works

How concentrated that is

The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.

United States: 24.0%China: 22.7%India: 16.1%Japan: 6.9%6 others listed: 30.3%24%largest
United States508 · 24.0%China482 · 22.7%India341 · 16.1%Japan146 · 6.9%6 others listed641 · 30.3%

Shares of the rows listed above, not of the whole node.

Which institutions lead Amoebic Infections and Treatments research?

By volume in 2022-now, All India Institute of Medical Sciences publishes the most Amoebic Infections and Treatments research, followed by Xinjiang Medical University and Post Graduate Institute of Medical Education and Research.

By volume, 2022-now

  1. 1 All India Institute of Medical SciencesIndia 30 works
  2. 2 Xinjiang Medical UniversityChina 19 works
  3. 3 Post Graduate Institute of Medical Education and ResearchIndia 18 works
  4. 4 Harvard UniversityUnited States 14 works
  5. 5 University of TikritIraq 14 works
  6. 6 Sichuan UniversityChina 14 works
  7. 7 Universidad Nacional Autónoma de MéxicoMexico 11 works
  8. 8 University of DelhiIndia 11 works
  9. 9 Banaras Hindu UniversityIndia 10 works
  10. 10 Capital Medical UniversityChina 10 works

Who are the leading researchers in Amoebic Infections and Treatments?

The most-cited researchers publishing on Amoebic Infections and Treatments include Shizuo Akira, Jean‐Louis Vincent and Didier Raoult.

  1. 1 Shizuo Akira Japan 342k citations
  2. 2 Jean‐Louis Vincent Belgium 262k citations
  3. 3 Didier Raoult France 232k citations
  4. 4 Alberto Mantovani Italy 224k citations
  5. 5 Ziad Ahmed Memish Saudi Arabia 224k citations

Ranked by citations received across their whole record, among researchers with at least three works on this topic.

What are the most cited papers in Amoebic Infections and Treatments?

The most cited paper in Amoebic Infections and Treatments is "Expert consensus for the diagnosis and treatment of cystic and alveolar echinococcosis in humans" (Enrico Brunetti, Peter M. Kern, Dominique Angèle Vuitton, 2009), with 2,217 citations. Next come "A new medium for the axenic cultivation of Entamoeba histolytica and other Entamoeba" (1,885) and "A Massive Outbreak in Milwaukee of Cryptosporidium Infection Transmitted through the Public Water Supply" (1,734).

Most cited papers
#PaperReleasedCitations
1 Expert consensus for the diagnosis and treatment of cystic and alveolar echinococcosis in humans Enrico Brunetti, Peter M. Kern, Dominique Angèle Vuitton · Acta Tropica Open access 20 Nov 2009 2,217
2 A new medium for the axenic cultivation of Entamoeba histolytica and other Entamoeba Louis S. Diamond, Dan R. Harlow, Carol C. Cunnick · Transactions of the Royal Society of Tropical Medicine and Hygiene 1978 1,885
3 A Massive Outbreak in Milwaukee of Cryptosporidium Infection Transmitted through the Public Water Supply Mac Kenzie Wr, Hoxie Nj, Proctor Me et al. · New England Journal of Medicine Open access 21 Jul 1994 1,734
4 Cachectin: More Than a Tumor Necrosis Factor Franklin H. Epstein, Bruce Beutler, Anthony Cerami · New England Journal of Medicine 12 Feb 1987 1,445
5 Characterization of ameboid microglia isolated from developing mammalian brain Dana Giulian, T J Baker · Journal of Neuroscience Open access Aug 1986 1,329
All 100 most cited papers, with filters and sorting

Where is Amoebic Infections and Treatments research done?

The largest centres of Amoebic Infections and Treatments research in 2022-now are Beijing (China), Mexico City (Mexico), New Delhi (India) and Tokyo (Japan).

Largest cities, 2022-now

  1. 1 BeijingChina 49 works
  2. 2 Mexico CityMexico 40 works
  3. 3 New DelhiIndia 40 works
  4. 4 TokyoJapan 39 works
  5. 5 ShanghaiChina 30 works
  6. 6 ParisFrance 30 works
  7. 7 LondonUnited Kingdom 28 works
  8. 8 TehranIran 25 works
  9. 9 GuangzhouChina 25 works
  10. 10 IstanbulTürkiye 25 works
See Amoebic Infections and Treatments on the map

Where is the best place to study Amoebic Infections and Treatments?

Among universities, judged by research, South China Agricultural University, Xinjiang Medical University and Harvard University score highest, combining citation excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.

0%10%20%30%mean 17.61%fractional works in this field (log) →share of work in the world top 10% →South China Agricult…Xinjiang Medical Uni…Harvard UniversityAll India Institute …
above the meannear itbelow it

One dot per university in the first ten of the table below, at the default weights. The upper left is the interesting corner: small places doing unusually strong work.

Citation excellenceshare of its work in the world top 10%, 2022-now and all time averaged
40%
Specialisationhow much of its work is in this field, counted up to 10× the world share
10%
Sizeits output in this field, on a log scale
30%
Growthoutput growth, counted from -20% to +20%
10%
Internationalshare of its work with a co-author abroad
10%
Each slider sets a weight; the share it gets of the score is beside it.
#UniversityScoreTop 10%SpecialisationWorksGrowth
1South China Agricultural UniversityChina 61.726.5%7.9×9 +17.0%
2Xinjiang Medical UniversityChina 56.616.7%34.6×19 +33.5%
3Harvard UniversityUnited States 54.715.4%1.4×14 +39.4%
4All India Institute of Medical SciencesIndia 53.08.0%8.5×30 -11.9%
5Central South UniversityChina 46.924.6%1.5×9 +58.8%
6Jilin UniversityChina 43.116.5%2.6×9 +102.3%
7Shanghai Jiao Tong UniversityChina 42.828.1%1.0×9 +37.8%
8Zhejiang UniversityChina 39.020.9%1.1×9 +1.5%
9Universidad Nacional Autónoma de MéxicoMexico 38.715.2%3.4×11 +15.5%
10Tunis El Manar UniversityTunisia 36.74.2%13.1×9 +40.6%

Universities only. The score blends citation excellence (40%), size (30%), specialisation (10%), growth (10%), international reach (10%), 2022-now; growth compares 2018-21 with 2022-25 and counts up to +20%, since a jump from a small base is mostly noise.

Every institution in Amoebic Infections and Treatments, country by country

Is Amoebic Infections and Treatments research growing?

Output in 2022-2025 was 2% higher than in 2018-2021, peaking in 2025. The fastest-growing topics are Amoebic Infections and Treatments.

still counting19801990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Amoebic Infections and Treatments as a percentage of every work published that year, 0.014% in 2024.

still counting0.020%0.040%Amoebic Infections and Treatments0.015% in 202519801990200020102020

Fractional works of Amoebic Infections and Treatments over all fractional works that year. How the balance of science has shifted.

How much of it reaches the world top 10%

Year by year.

still counting5%10%15%Amoebic Infections and Treatments10.5% in 2025200020102020

Of each year's works in it, the share that reached the world's 10% most cited for their field and year. A field is the world for its own topics, so there is no other line to hold it against.

Which topics inside it are moving

Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.

Discussion

Ask a question or share a note about Amoebic Infections and Treatments. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.